Teladoc Health (TDOC) Cash from Financing Activities (2014 - 2026)

Teladoc Health's Cash from Financing Activities history runs 13 years deep, the most recent figure standing at -$2.4 million for Q1 2026.

• In Q1 2026, Cash from Financing Activities fell 418.47% year-over-year to -$2.4 million; the TTM figure through Mar 2026 stood at -$554.9 million (down 7669.85% YoY), while the FY2025 annual figure was -$551.7 million, down 6736.81% from the prior year.
• Cash from Financing Activities came in at -$2.4 million for Q1 2026 at Teladoc Health, down from $1.1 million in the prior quarter.
• In the past five years, Cash from Financing Activities ranged from a high of $5.1 million in Q3 2023 to a low of -$549.9 million in Q2 2025.
• A 5-year average of -$31.1 million and a median of $1.1 million in 2025 frame the typical range for Cash from Financing Activities.
• Across the five-year window, Cash from Financing Activities soared 699.37% in 2023 and sank 14552.9% in 2025, its largest moves.
• Teladoc Health's Cash from Financing Activities stood at $4.4 million in 2022, then tumbled by 140.52% to -$1.8 million in 2023, then jumped by 215.94% to $2.1 million in 2024, then sank by 46.36% to $1.1 million in 2025, then plunged by 321.83% to -$2.4 million in 2026.
• According to Business Quant data, Cash from Financing Activities over the past three periods registered -$2.4 million, $1.1 million, and -$3.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison